{"id":"https://openalex.org/W7147446916","doi":"https://doi.org/10.1158/0008-5472.31923394","title":"Supplemental Figure 16 from Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer","display_name":"Supplemental Figure 16 from Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer","publication_year":2026,"publication_date":"2026-04-02","ids":{"openalex":"https://openalex.org/W7147446916","doi":"https://doi.org/10.1158/0008-5472.31923394"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.31923394","doi":"https://doi.org/10.1158/0008-5472.31923394","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.31923394","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.31923394","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088533475","display_name":"Sarah K. Herzog","orcid":"https://orcid.org/0000-0003-3782-7389","observed_orcids":["https://orcid.org/0000-0003-3782-7389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah K. Herzog","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3782-7389","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053532805","display_name":"Jessica H. Stevens","orcid":"https://orcid.org/0009-0005-9741-9928","observed_orcids":["https://orcid.org/0009-0005-9741-9928"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica H. Stevens","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-9741-9928","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022101967","display_name":"Guowei gu","orcid":"https://orcid.org/0000-0001-8845-4055","observed_orcids":["https://orcid.org/0000-0001-8845-4055"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guowei Gu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8845-4055","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055660362","display_name":"Sandra L. Grimm","orcid":"https://orcid.org/0000-0002-0682-3134","observed_orcids":["https://orcid.org/0000-0002-0682-3134"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra L. Grimm","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0682-3134","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120061357","display_name":"Kloma T Cardoza","orcid":"https://orcid.org/0009-0006-0488-7894","observed_orcids":["https://orcid.org/0009-0006-0488-7894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kloma Cardoza","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-0488-7894","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122007666","display_name":"Autumn G.M. Hawkins","orcid":"https://orcid.org/0009-0001-8189-3159","observed_orcids":["https://orcid.org/0009-0001-8189-3159"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Autumn G.M. Hawkins","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-8189-3159","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022989159","display_name":"Hangqing Lin","orcid":"https://orcid.org/0009-0009-7691-8364","observed_orcids":["https://orcid.org/0009-0009-7691-8364"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hangqing Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-7691-8364","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008477330","display_name":"Daniela Ramos","orcid":"https://orcid.org/0000-0002-8940-0232","observed_orcids":["https://orcid.org/0000-0002-8940-0232","https://orcid.org/0000-0002-3848-6478"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniela Ramos","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3848-6478","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027523922","display_name":"Amanda R. Beyer","orcid":"https://orcid.org/0009-0009-9244-1439","observed_orcids":["https://orcid.org/0009-0009-9244-1439"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda R. Beyer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-9244-1439","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132660789","display_name":"David G. Edwards","orcid":"https://orcid.org/0000-0001-8002-0607","observed_orcids":["https://orcid.org/0000-0001-8002-0607"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David G. Edwards","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8002-0607","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074873339","display_name":"Derek J. Dustin","orcid":"https://orcid.org/0000-0002-3566-0282","observed_orcids":["https://orcid.org/0000-0002-3566-0282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Derek Dustin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3566-0282","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121999354","display_name":"Harry J. Yang","orcid":"https://orcid.org/0009-0008-8758-5705","observed_orcids":["https://orcid.org/0009-0008-8758-5705"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harry J. Yang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-8758-5705","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132625812","display_name":"Nicole Liang","orcid":"https://orcid.org/0009-0009-7459-8360","observed_orcids":["https://orcid.org/0009-0009-7459-8360"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicole Liang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-7459-8360","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001922429","display_name":"Ashfia Fatima Khan","orcid":"https://orcid.org/0000-0002-1730-5383","observed_orcids":["https://orcid.org/0000-0002-1730-5383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashfia F. Khan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1730-5383","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132732093","display_name":"Tasneem Bawa-Khalfe","orcid":"https://orcid.org/0000-0002-5376-4392","observed_orcids":["https://orcid.org/0000-0002-5376-4392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tasneem Bawa-Khalfe","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5376-4392","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060285832","display_name":"Daniel James McGrail","orcid":"https://orcid.org/0000-0002-6669-6069","observed_orcids":["https://orcid.org/0000-0002-6669-6069","https://orcid.org/0000-0002-3729-2487"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. McGrail","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6669-6069","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044419431","display_name":"Shiaw\u2010Yih Lin","orcid":"https://orcid.org/0000-0002-3838-0358","observed_orcids":["https://orcid.org/0000-0002-3838-0358"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shiaw-Yih Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3838-0358","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052755605","display_name":"Cristian Coarfa","orcid":"https://orcid.org/0000-0002-4183-4939","observed_orcids":["https://orcid.org/0000-0002-4183-4939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristian Coarfa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4183-4939","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5054255756","display_name":"Suzanne A.W. Fuqua","orcid":"https://orcid.org/0000-0001-8886-5161","observed_orcids":["https://orcid.org/0000-0001-8886-5161"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suzanne A.W. Fuqua","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8886-5161","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/esr1-mutations","display_name":"ESR1 mutations","score":0.8040000200271606},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9309999942779541},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.8309999704360962},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8519999980926514},{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":0.7480000257492065},{"id":"https://openalex.org/keywords/fulvestrant-resistance","display_name":"fulvestrant resistance","score":0.8899999856948853},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.8809999823570251},{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5630000233650208},{"id":"https://openalex.org/keywords/therapeutic-vulnerabilities","display_name":"therapeutic vulnerabilities","score":0.7009999752044678},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.9330000281333923},{"id":"https://openalex.org/keywords/zr-75-1-cells","display_name":"ZR-75-1 cells","score":0.9959999918937683}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.8123999834060669},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5615000128746033},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.557699978351593},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5548999905586243},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5170999765396118},{"id":"https://openalex.org/C99476002","wikidata":"https://www.wikidata.org/wiki/Q42297","display_name":"Analysis of variance","level":2,"score":0.48919999599456787},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45989999175071716},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.45339998602867126},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4521999955177307},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4275999963283539},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42480000853538513},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4169999957084656},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.3538999855518341},{"id":"https://openalex.org/C2986587452","wikidata":"https://www.wikidata.org/wiki/Q938438","display_name":"Statistical analysis","level":2,"score":0.35040000081062317},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.33489999175071716},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33340001106262207},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.31220000982284546},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.3025999963283539},{"id":"https://openalex.org/C2994372470","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell lines","level":4,"score":0.30090001225471497},{"id":"https://openalex.org/C95713431","wikidata":"https://www.wikidata.org/wiki/Q631425","display_name":"Vulnerability (computing)","level":2,"score":0.27649998664855957},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2727000117301941},{"id":"https://openalex.org/C51853150","wikidata":"https://www.wikidata.org/wiki/Q14911754","display_name":"Cyclin-dependent kinase 4","level":5,"score":0.2709999978542328},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2709999978542328},{"id":"https://openalex.org/C16685009","wikidata":"https://www.wikidata.org/wiki/Q335057","display_name":"Andrology","level":1,"score":0.26930001378059387}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.31923394","doi":"https://doi.org/10.1158/0008-5472.31923394","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.31923394","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.31923394","doi":"https://doi.org/10.1158/0008-5472.31923394","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.31923394","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4411287310","https://openalex.org/W4412974562","https://openalex.org/W3123311824","https://openalex.org/W3013500592","https://openalex.org/W3013041600","https://openalex.org/W3083257290","https://openalex.org/W3005787166","https://openalex.org/W4408445370","https://openalex.org/W4396587803","https://openalex.org/W7083287160"],"abstract_inverted_index":{"Evaluation":[0],"of":[1,16,26,46,87],"CDK4/6":[2,30],"inhibitor":[3],"cross-resistance":[4],"in":[5,102,109],"FulvR":[6,17,59],"and":[7],"AbemaR":[8,47,66],"breast":[9],"cancer":[10],"models":[11],"a.":[12],"MTT":[13,43,98],"growth":[14,44],"assay":[15,45],"vs":[18],"parental":[19,49,55,61,68,137],"MCF-7":[20,50,56],"cells":[21,70],"treated":[22,71],"with":[23,72],"indicated":[24],"concentrations":[25,108],"Abema":[27,39,80],"or":[28,38,64,79],"b.":[29],"inhibitors":[31],"ribociclib":[32,73],"(1.5":[33,74],"\u00b5M),":[34,75],"palbociclib":[35,76],"(200":[36,77],"nM)":[37,78],"(500":[40,81],"nM).":[41,82],"c.":[42],"versus":[48,54,60,67],"cells,":[51,57,63],"d.":[52],"F+A":[53],"e.":[58],"ZR75-1":[62,69],"f.":[65],"Bars":[83],"represent":[84],"mean+standard":[85],"deviation":[86],"%viability":[88],"normalized":[89],"to":[90,136],"untreated":[91],"controls":[92],"within":[93],"each":[94],"cell":[95,111,134],"line.":[96],"All":[97],"assays":[99],"were":[100],"performed":[101,123],"minimum":[103],"technical":[104],"quadruplicate":[105],"at":[106],"all":[107,110,132],"lines.":[112],"Cell":[113],"lines":[114,135],"are":[115],"labeled":[116],"by":[117],"biological":[118],"replicate.":[119],"Statistical":[120],"analysis":[121],"was":[122],"utilizing":[124],"2-way":[125],"ANOVA":[126],"corrected":[127],"for":[128],"multiple":[129],"comparisons":[130],"comparing":[131],"resistant":[133],"controls.":[138],"*p-val<0.05,":[139],"**p-val<0.01,":[140],"***p-val<0.001,":[141],"****p-val<0.0001.":[142]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2026-04-02T00:00:00"}